Literature DB >> 17215875

ERp57 and PDI: multifunctional protein disulfide isomerases with similar domain architectures but differing substrate-partner associations.

P Maattanen1, G Kozlov, K Gehring, D Y Thomas.   

Abstract

Secretory proteins become folded and acquire stabilizing disulfide bonds in the endoplasmic reticulum (ER). Correct disulfide bond formation is a key step in ER quality control (ERQC). Proteins with incorrect disulfide bonds are recognized by the quality control machinery and are retrotranslocated into the cytosol where they are degraded by the proteasome. The mammalian ER contains 17 disulfide isomerases and at least one of them, ERp57, works in conjunction with the ER lectin-like chaperones calnexin and calreticulin. The targeting of ERp57 to calnexin-calreticulin is mediated by its noncatalytic b' domain, and analogous domains in other disulfide isomerases likely determine their substrate and partner preferences. This review discusses some explanations for the multiplicity of disulfide isomerases and highlights structural differences in the b' domains of PDI and ERp57 as an example of how noncatalytic domains define specialized roles in oxidative folding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17215875     DOI: 10.1139/o06-186

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  41 in total

Review 1.  The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?

Authors:  Martin McLaughlin; Koen Vandenbroeck
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 2.  The activities and function of molecular chaperones in the endoplasmic reticulum.

Authors:  Teresa M Buck; Christine M Wright; Jeffrey L Brodsky
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

3.  Crystal structure of human ERp44 shows a dynamic functional modulation by its carboxy-terminal tail.

Authors:  Likun Wang; Lei Wang; Stefano Vavassori; Shengjian Li; Huimin Ke; Tiziana Anelli; Massimo Degano; Riccardo Ronzoni; Roberto Sitia; Fei Sun; Chih-Chen Wang
Journal:  EMBO Rep       Date:  2008-06-13       Impact factor: 8.807

Review 4.  Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy.

Authors:  Yanfen Liu; Yihong Ye
Journal:  Cell Res       Date:  2011-05-03       Impact factor: 25.617

Review 5.  Multiple catalytically active thioredoxin folds: a winning strategy for many functions.

Authors:  Emilia Pedone; Danila Limauro; Katia D'Ambrosio; Giuseppina De Simone; Simonetta Bartolucci
Journal:  Cell Mol Life Sci       Date:  2010-07-13       Impact factor: 9.261

6.  Identification of hepsin and protein disulfide isomerase A3 as targets of gelatinolytic action in rat ovarian granulosa cells during the periovulatory period.

Authors:  Katherine Rosewell; Linah Al-Alem; Feixue Li; Brian Kelty; Thomas E Curry
Journal:  Biol Reprod       Date:  2011-07-06       Impact factor: 4.285

Review 7.  Unfolded protein response in pollen development and heat stress tolerance.

Authors:  Sotirios Fragkostefanakis; Anida Mesihovic; Yangjie Hu; Enrico Schleiff
Journal:  Plant Reprod       Date:  2016-03-29       Impact factor: 3.767

8.  Prediction of reversibly oxidized protein cysteine thiols using protein structure properties.

Authors:  Ricardo Sanchez; Megan Riddle; Jongwook Woo; Jamil Momand
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

9.  Generating an unfoldase from thioredoxin-like domains.

Authors:  Michele L Forster; James J Mahn; Billy Tsai
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

10.  Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.

Authors:  Charles Kwok-chong Li; Paul Knopp; Halima Moncrieffe; Bhanu Singh; Sonia Shah; Kanneboyina Nagaraju; Hemlata Varsani; Bin Gao; Lucy R Wedderburn
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.